SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMAT - ultrafast tomography for coronary artery disease

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: TA2K who wrote (3564)8/21/2000 10:55:14 AM
From: Savant  Read Replies (1) of 3725
 
Heavy petting.
Positron Announces Shipment of Pet Scanner to Nishidai Clinic
'Diagnostic Imaging Center' in Tokyo; First of Previously Announced
Five-Unit Pet Order

HOUSTON, Aug 21, 2000 (BUSINESS WIRE) -- Positron Corporation (POSC.OB)
announced today that it has shipped the first Positron-HZL(TM) positron emission
tomography (PET) scanner to the Nishidai Clinic (Diagnostic Imaging Center) in
Tokyo. This system sale will be recorded in the Company's third quarter
financial results.

Ms. Sachiko Kinoshita, President of Imatron-Japan, stated, "We are very pleased
that Positron has shipped the first of the five PET scanners ordered by Nishidai
Clinic (Diagnostic Imaging Center) in Tokyo. This order for five scanners
validates the growing and widespread interest in Japan for this unique
technology."

Gary Brooks, President of Positron, commented, "We are pleased to announce the
first sale of the Nishidai Clinic order. Nishidai Clinic is expected to be the
largest free-standing PET and imaging center in the Far East. This vote of
confidence in Positron's unique applications in oncology and neurology will
assist us in securing future orders. We look forward to announcing the remaining
sales from this previously announced order for five scanners."

Positron Corporation is primarily engaged in designing, manufacturing, marketing
and supporting advanced medical imaging devices utilizing positron emission
tomography (PET) technology under the trade name POSICAM(TM) systems. POSICAM
systems incorporate patented and proprietary technology for the diagnosis and
treatment of patients in the areas of oncology, cardiology and neurology.
POSICAM systems are in use at leading medical facilities, including the
Cleveland Clinic Foundation, Yale University/Veterans Administration, Crawford
Long Hospital, Hermann Hospital, and Hadassah Hebrew University Hospital in
Jerusalem, Israel, The Coronary Disease Reversal Center in Buffalo, New York,
and the Nishidai Clinic in Tokyo.

Best, Savant
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext